A systematic approach for early identification of BP effects during development of new drugs.
Michael A. Weber, MD
Advertisement
Articles by Michael A. Weber, MD
More attention is being paid to blood pressure effects in new chemical entities under development for non-hypertension indications.
Advertisement
Latest Updated Articles
A Proposed Approach for Blood Pressure Evaluation During Early Phase Human Trials of New DrugsPublished: July 22nd 2014 | Updated:
- Blood Pressure Evaluation During Early Phase Trials
Published: October 1st 2014 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Getting Clinical Outsourcing Right
2
Modernizing Recruitment with Data, HCP Networks, and Last Mile Support
3
ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes
4
Alkermes’ Alixorexton Shows Positive Phase II Results in Narcolepsy Type 2
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
